SPY334.33+2.22 0.67%
DIA273.90+1.90 0.70%
IXIC11,108.07+109.67 1.00%

JMP Securities Maintains Market Outperform on Ultragenyx Pharmaceutical, Lowers Price Target to $80

JMP Securities maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Market Outperform and lowers the price target from $82 to $80.

Benzinga · -

JMP Securities maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Market Outperform and lowers the price target from $82 to $80.